98%
921
2 minutes
20
Aim: To generate and validate predictive models for blood-brain permeation (BBB) of CNS molecules using the QSPR approach.
Background: Prediction of molecules crossing BBB remains a challenge in drug delivery. Predictive models are designed for the evaluation of a set of preclinical drugs which may serve as alternatives for determining BBB permeation by experimentation.
Objective: The objective of the present study was to generate QSPR models for the permeation of CNS molecules across BBB and its validation using existing in-house leads.
Methods: The present study envisaged the determination of the set of molecular descriptors which are considered significant correlative factors for BBB permeation property. Quantitative Structure- Property Relationship (QSPR) approach was followed to describe the correlation between identified descriptors for 45 molecules and highest, moderate and least BBB permeation data. The molecular descriptors were selected based on drug-likeness, hydrophilicity, hydrophobicity, polar surface area, etc. of molecules that served the highest correlation with BBB permeation. The experimental data in terms of log BB were collected from available literature, subjected to 2D-QSPR model generation using a regression analysis method like Multiple Linear Regression (MLR).
Results: The best QSPR model was Model 3, which exhibited regression coefficient as R= 0.89, F = 36; Q= 0.7805 and properties such as polar surface area, hydrophobic hydrophilic distance, electronegativity, etc., which were considered key parameters in the determination of the BBB permeability. The developed QSPR models were validated with in-house 1,5-benzodiazepines molecules and correlation studies were conducted between experimental and predicted BBB permeability.
Conclusion: The QSPR model 3 showed predictive results that were in good agreements with experimental results for blood-brain permeation. Thus, this model was found to be satisfactory in achieving a good correlation between selected descriptors and BBB permeation for benzodiazepines and tricyclic compounds.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1573409916666200131114018 | DOI Listing |
Int J Pharm
August 2025
Department of Organic Chemistry, Israel Institute for Biological Research, Ness-Ziona 74100, Israel. Electronic address:
The present study describes the ability of different water soluble pillararenes (PAs) to complex and solubilize Idebenone (IDE), as a model drug, and the results are compared to previously reported complexes of IDE with cyclodextrins (CDs). We show that P[5]As strongly bind IDE, with the CDs showing lower binding and P[6]As exhibiting the weakest binding. The differences between the weak and strong complexes reached above two orders of magnitude in the binding constants.
View Article and Find Full Text PDFFront Behav Neurosci
August 2025
Universidad Nacional De Córdoba, Facultad De Ciencias Químicas, Departamento De Farmacología Otto Orshinger, Córdoba, Argentina.
Introduction: Traumatic brain injury is the leading cause of death and disability in individuals under 40 years old. It induces various neuropathological outcomes, including cognitive, emotional, and physiological deficits, likely linked to early neuroinflammatory processes. In an animal model, mild traumatic brain injury (mTBI) has been shown to elevate oxidative stress biomarkers, such as advanced oxidation protein products (AOPP) and malondialdehyde (MDA), which persist for over a week.
View Article and Find Full Text PDFProtein Sci
September 2025
Center for Synaptic Neuroscience and Technology (NSYN@UniGe), Istituto Italiano di Tecnologia, Genoa, Italy.
In the blood-brain barrier (BBB), endothelial cells are joined by tight junctions (TJs), multi-protein assemblies that seal the paracellular space and restrict molecular transport. Among the BBB TJ proteins, Claudin-5 (Cldn15) is the most abundant one. Structural models for claudin complexes, first introduced for channel-forming, selectively permeable claudins, comprise protomers arranged to form paracellular pores that regulate transport by electrostatic and/or steric effects arising from pore-lining residues.
View Article and Find Full Text PDFInt J Pharm
October 2025
Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, Telangana, INDIA. Electronic address:
Glioblastoma (GBM), being a formidable disease, has emerged as a ticking time bomb owing to the unavailability of effective treatment modalities, poor prognosis, and limited life expectancy. For effective GBM treatment, intracellular delivery of therapeutics is a dire necessity, which is hindered by the blood-brain barrier (BBB) and blood-tumor barrier (BTB). Nanocarriers (NCs) have emerged as novel biomedical tools for delivering therapeutics for the last so many years.
View Article and Find Full Text PDFEur J Med Chem
November 2025
Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Sıhhiye, Ankara, 06100, Turkey. Electronic address:
Neurodegenerative diseases are multifactorial disorders characterized by protein misfolding, oxidative stress, and neuroinflammation, finally resulting in neuronal loss and cognitive dysfunctions. Nowadays, an attractive strategy to improve the classical treatments is the development of multitarget-directed molecules able to synergistically interact with different enzymes and/or receptors. A novel series of chiral carbamate and carbamothioate derivatives were designed, synthesized, and investigated as inhibition of cholinesterases and monoamine oxidases, anti-β-amyloid aggregation and antioxidant activities against Alzheimer's disease.
View Article and Find Full Text PDF